A carregar...
INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES
Much attention has been recently paid to the study of interleukin 6 (IL-6) among the cytokines involved in the development of immune inflammatory rheumatic diseases (IIRDs). The introduction of monoclonal antibodies that inhibit the activity of IL-6 (tocilizumab, TCZ) in clinical practice in 2010 is...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
IMA-PRESS LLC
2018-01-01
|
| Colecção: | Научно-практическая ревматология |
| Assuntos: | |
| Acesso em linha: | https://rsp.mediar-press.net/rsp/article/view/2461 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|